The label update provides an option for patients who have received at least 1 approved systemic therapy if TNF blockers are clinically inadvisable.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback